Citation: Sg. Gordon et Wp. Mielicki, CANCER PROCOAGULANT - A FACTOR-X ACTIVATOR, TUMOR-MARKER AND GROWTH-FACTOR FROM MALIGNANT-TISSUE, Blood coagulation & fibrinolysis, 8(2), 1997, pp. 73-86
Citation: Wp. Mielicki et al., IMMUNOSPECIFIC POLYCLONAL ANTIBODIES AGAINST CANCER PROCOAGULANT (EC-3.4.22.26), Thrombosis and haemostasis, 1997, pp. 110-110
Authors:
FALANGA A
CONSONNI R
MARCHETTI M
MIELICKI WP
RAMBALDI A
LANOTTE M
GORDON SG
BARBUI T
Citation: A. Falanga et al., CANCER PROCOAGULANT IN THE HUMAN PROMYELOCYTIC CELL-LINE NB4 AND ITS MODULATION BY ALL-TRANS-RETINOIC ACID, Leukemia, 8(1), 1994, pp. 156-159
Citation: Wp. Mielicki et al., NEW IMMUNOCAPTURE ENZYME (ICE) ASSAY FOR QUANTIFICATION OF CANCER PROCOAGULANT ACTIVITY - STUDIES OF INHIBITORS, Thrombosis and haemostasis, 71(4), 1994, pp. 456-460
Authors:
MIELICKI WP
KOZWICH DL
KRAMER LC
GORDON SG
Citation: Wp. Mielicki et al., EFFECT OF DIVALENT IONS ON THE ACTIVITY OF CANCER PROCOAGULANT, Archives of biochemistry and biophysics, 314(1), 1994, pp. 165-170
Citation: Wp. Mielicki et Sg. Gordon, 3-STAGE CHROMOGENIC ASSAY FOR THE ANALYSIS OF ACTIVATION PROPERTIES OF FACTOR-X BY CANCER PROCOAGULANT, Blood coagulation & fibrinolysis, 4(3), 1993, pp. 441-446
Citation: Wp. Mielicki et Sg. Gordon, IMMUNOENZYMATIC ASSAY FOR QUANTITATION OF CANCER PROCOAGULANT ACTIVITY AND STUDY OF ITS INHIBITORS, Thrombosis and haemostasis, 69(6), 1993, pp. 1042-1042